Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading Down 1% – What’s Next?

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF)’s stock price dropped 1% during mid-day trading on Monday . The company traded as low as $2.51 and last traded at $2.8920. Approximately 13,635 shares changed hands during mid-day trading, an increase of 7% from the average daily volume of 12,703 shares. The stock had previously closed at $2.9220.

Medexus Pharmaceuticals Stock Performance

The firm’s 50-day simple moving average is $2.36 and its 200 day simple moving average is $2.12.

About Medexus Pharmaceuticals

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.